Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches

Biomarkers

Volumn 16, Issue 5, 2011, Pages 393-404

  Abdel Rahman, Sherif Z ^a   El Zein, Randa A ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Biomarkers; Cancer; DNA repair; Environmental exposure; Haplotype; Mutagen sensitivity; Polymorphisms

Indexed keywords

BIOLOGICAL MARKER;

BIOLOGICAL MONITORING; CANCER SUSCEPTIBILITY; CYTOGENETICS; DNA POLYMORPHISM; DNA REPAIR; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; PERIPHERAL LYMPHOCYTE; REVIEW;

ANIMALS; CELL CYCLE; CELLS, CULTURED; DNA REPAIR; HUMANS; MICRONUCLEUS TESTS; MUTAGENS; POLYMORPHISM, GENETIC;

EID: 79960807517     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.577237     Document Type: Review

References (119)

1. Abdel-Rahman SZ, El-Zein RA. (2000). The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specifc nitrosamine NNK. Cancer Lett 159:63-71.
2. Afatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. (2004). Efect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specifc nitrosamine NNK. Environ Mol Mutagen 44:65-73. (Pubitemid 38982073)
3. Aka P, Mateuca R, Buchet JP, Tierens H, Kirsch-Volders M. (2004). Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 556:169-181. (Pubitemid 39371190)
4. Angelini S, Kumar R, Carbone F, Bermejo JL, Mafei F, Cantelli-Forti G, Hemminki K, Hrelia P. (2008). Inherited susceptibility to bleomycin-induced micronuclei: Correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity. Mutat Res 638:90-97.
5. Au WW, Bechtold WE, Whorton EB Jr, Legator MS. (1995a). Chromosome aberrations and response to γ-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutat Res 334:125-130.
6. Au WW, Giri AK, Ruchirawat M. (2010). Challenge assay: A functional biomarker for exposure-induced DNA repair defciency and for risk of cancer. Int J Hyg Environ Health 213:32-39.
7. Au WW, Lane RG, Legator MS, Whorton EB, Wilkinson GS, Gabehart GJ. (1995b). Biomarker monitoring of a population residing near uranium mining activities. Environ Health Perspect 103:466-470.
8. Au WW, Salama SA. (2005). Use of biomarkers to elucidate genetic susceptibility to cancer. Environ Mol Mutagen 45:222-228.
9. Au WW, Salama SA, Sierra-Torres CH. (2003). Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111:1843-1850. (Pubitemid 37526965)
10. Au WW, Sierra-Torres CH, Cajas-Salazar N, Shipp BK, Legator MS. (1999). Cytogenetic effects from exposure to mixed pesticides and the infuence from genetic susceptibility. Environ Health Perspect 107:501-505. (Pubitemid 29341376)
11. Baeyens A, Tierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A. (2002). Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379-1385. (Pubitemid 36044311)
12. Baeyens A, Tierens H, Claes K, Poppe B, De Ridder L, Vral A. (2004). Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 80:745-756. (Pubitemid 40126091)
13. Baeyens A, Van Den Broecke R, Makar A, Tierens H, De Ridder L, Vral A. (2005). Chromosomal radiosensitivity in breast cancer patients: Infuence of age of onset of the disease. Oncol Rep 13:347-353.
14. Bau DT, Mau YC, Ding SL, Wu PE, Shen CY. (2007). DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 28:1726-1730.
15. Berwick M, Vineis P. (2000). Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J Natl Cancer Inst 92:874-897. (Pubitemid 30429188)
16. Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. (2000). Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 60:1619-1625. (Pubitemid 30183433)
17. Bonassi S, Znaor A, Norppa H, Hagmar L. (2004). Chromosomal aberrations and risk of cancer in humans: An epidemiologic perspective. Cytogenet Genome Res 104:376-382. (Pubitemid 38721106)
18. Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q. (1996). Mutagen sensitivity and risk of gliomas: A case-control analysis. Cancer Res 56:1484-1486. (Pubitemid 26104006)
19. Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. (2001). Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553-1557.
20. Cazaux C. (2010). Genetic instability as a driver for oncogenesis. Bull Cancer 97:1241-1251.
21. Shibata D. (2011). Mutation and epigenetic molecular clocks in cancer. Carcinogenesis 32:123-128.
22. Chanvaivit S, Navasumrit P, Hunsonti P, Autrup H, Ruchirawat M. (2007). Exposure assessment of benzene in Tai workers, DNA-repair capacity and infuence of genetic polymorphisms. Mutat Res 626:79-87. (Pubitemid 44895600)
23. Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL. (2006). Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: A prospective analysis. Cancer Epidemiol Biomarkers Prev 15:1935-1940. (Pubitemid 44664271)
24. Cheng J, Leng S, Dai Y, Huang C, Pan Z, Niu Y, Li B, Zheng Y. (2007). Association between nucleotide excision repair gene polymorphisms and chromosomal damage in coke-oven workers. Biomarkers 12:76-86. (Pubitemid 46562627)
25. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. (1998). Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 7:465-468. (Pubitemid 28354107)
26. Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang ZF, Tobi H, Braakhuis BJ, Snow GB. (1996). Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88:530-535. (Pubitemid 26118723)
27. Cloutier JF, Drouin R, Weinfeld M, O'Connor TR, Castonguay A. (2001). Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J Mol Biol 313:539-557. (Pubitemid 33052286)
28. Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, Baccelliere L, Cozzi R. (2008). Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res 638:75-82.
29. Decordier I, De Bont K, De Bock K, Mateuca R, Roelants M, Ciardelli R, Haumont D, Knudsen LE, Kirsch-Volders M. (2007). Genetic susceptibility of newborn daughters to oxidative stress. Toxicol Lett 172:68-84. (Pubitemid 47126219)
30. Decordier I, Loock K V, Kirsch-Volders M. (2010). Phenotyping for DNA repair capacity. Mutat Res 705:107-129.
31. Decordier I, Mateuca R, Kirsch-Volders M. (2011). Micronucleus assay and labeling of centromeres with FISH technique. Methods Mol Biol 691:115-136.
32. El-Zein R, Etzel CJ, Lopez MS, Gu Y, Spitz MR, Strom SS. (2006a). Human sensitivity to PhIP: A novel marker for prostate cancer risk. Mutat Res 601:1-10. (Pubitemid 44528592)
33. El-Zein R, Vral A, Etzel CJ. (2011). Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 26:101-106.
34. El-Zein RA, Fenech M, Lopez MS, Spitz MR, Etzel CJ. (2008). Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17:1111-1119.
35. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. (2006b). Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66:6449-6456.
36. El-Zein R, Shaw P, Tyring SK, Au WW. (1995). Chromosomal radiosensitivity of lymphocytes from skin cancer-prone patients. Mutat Res 335:143-149.
37. Fenech M. (2000). The in vitro micronucleus technique. Mutat Res 455:81-95.
38. Fenech M. (2007). Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084-1104. (Pubitemid 46901289)
39. Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY. (2003). Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res 63:2440-2446.
40. Gabriel SB, Schafner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. (2002). The structure of haplotype blocks in the human genome. Science 296:2225-2229. (Pubitemid 34680308)
41. Godderis L, Aka P, Mateuca R, Kirsch-Volders M, Lison D, Veulemans H. (2006). Dose-dependent infuence of genetic polymorphisms on DNA damage induced by styrene oxide, ethylene oxide and γ-radiation. Toxicology 219:220-229. (Pubitemid 43120722)
42. Godderis L, De Boeck M, Haufroid V, Emmery M, Mateuca R, Gardinal S, Kirsch-Volders M, Veulemans H, Lison D. (2004). Infuence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers. Environ Mol Mutagen 44:293-303. (Pubitemid 39447233)
43. Goode EL, Ulrich CM, Potter JD. (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513-1530. (Pubitemid 36020002)
44. Grossman L. (1997). Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect 105 Suppl 4:927-930. (Pubitemid 27372983)
45. Hanawalt PC. (1995). DNA repair comes of age. Mutat Res 336:101-113.
46. Hecht SS. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specifc N-nitrosamines. Chem Res Toxicol 11:559-603.
47. Hemminki K, Xu G, Angelini S, Snellman E, Jansen CT, Lambert B, Hou SM. (2001). XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis 22:1185-1188. (Pubitemid 32737333)
48. Hill CE, Afatato AA, Wolfe KJ, Lopez MS, Hallberg CK, Canistro D, Abdel-Rahman SZ. (2005b). Gender diferences in genetic damage induced by the tobacco-specifc nitrosamine NNK and the infuence of the Tr241Met polymorphism in the XRCC3 gene. Environ Mol Mutagen 46:22-29. (Pubitemid 41099102)
49. 6- methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specifc nitrosamine carcinogen NNK. Pharmacogenet Genomics 15:571-578. (Pubitemid 41044243)
50. Hiom K. (2010). Coping with DNA double strand breaks. DNA Repair (Amst) 9:1256-1263.
51. Hsieh P. (2001). Molecular mechanisms of DNA mismatch repair. Mutat Res 486:71-87. (Pubitemid 32568409)
52. Hsu TC. (1983). Genetic instability in the human population: A working hypothesis. Hereditas 98:1-9. (Pubitemid 13087385)
53. Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C. (1989). Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis. Int J Cancer 43:403-409. (Pubitemid 19092320)
54. Hsu TC, Spitz MR, Schantz SP. (1991). Mutagen sensitivity: A biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1:83-89.
55. Hulla JE, Miller MS, Taylor JA, Hein DW, Furlong CE, Omiecinski CJ, Kunkel TA. (1999). Symposium overview: The role of genetic polymorphism and repair defciencies in environmental disease. Toxicol Sci 47:135-143. (Pubitemid 29214819)
56. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. (2009). Silent (synonymous) SNPs: Should we care about them? Methods Mol Biol 578:23-39.
57. Ishikawa T, Ide F, Qin X, Zhang S, Takahashi Y, Sekiguchi M, Tanaka K, Nakatsuru Y. (2001). Importance of DNA repair in carcinogenesis: Evidence from transgenic and gene targeting studies. Mutat Res 477:41-49. (Pubitemid 32480187)
58. Johnson AD, Wang D, Sadee W. (2005). Polymorphisms afecting gene regulation and mRNA processing: Broad implications for pharmacogenetics. Pharmacol Ter 106:19-38. (Pubitemid 40392460)
59. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. (2007). A "silent" polymorphism in the MDR1 gene changes substrate specifcity. Science 315:525-528. (Pubitemid 46175758)
60. Kimura M, Umegaki K, Higuchi M, Tomas P, Fenech M. (2004). Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and ribofavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134:48-56. (Pubitemid 38057422)
61. Kinslow CJ, El-Zein RA, Hill CE, Wicklife JK, Abdel-Rahman SZ. (2008). Single nucleotide polymorphisms 5' upstream the coding region of the NEIL2 gene infuence gene transcription levels and alter levels of genetic damage. Genes Chromosomes Cancer 47:923-932.
62. Kirsch-Volders M, Elhajouji A, Cundari E, Van Hummelen P. (1997). The in vitro micronucleus test: A multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat Res 392:19-30. (Pubitemid 27327005)
63. Kirsch-Volders M, Vanhauwaert A, De Boeck M, Decordier I. (2002). Importance of detecting numerical versus structural chromosome aberrations. Mutat Res 504:137-148. (Pubitemid 34775107)
64. Kolodner RD, Marsischky GT. (1999). Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9:89-96. (Pubitemid 29080392)
65. Leng S, Stidley CA, Bernauer AM, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Crowell RE, Belinsky SA. (2008). Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers. Carcinogenesis 29:1380-1385.
66. Lin J, Swan GE, Shields PG, Benowitz NL, Gu J, Amos CI, de Andrade M, Spitz MR, Wu X. (2007). Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: Genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 16:2065-2071. (Pubitemid 47621181)
67. Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML. (2010a). Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Carcinogenesis 31:1762-1769.
68. Liu N, Guan W, Meng H, Cui T, Li Z, Cheng J, Xiao J, Wang X, Li B. (2010b). Association of XRCC4 polymorphisms and chromosomal damage levels in 1,3-butadiene workers. Wei Sheng Yan Jiu 39:407-411.
69. López de Mesa R, López de Ceráin Salsamendi A, Sierrasesúmaga Ariznabarreta L, Calasanz Abínzano MJ, Patiño-García A. (2002). Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients. Mutagenesis 17:171-175.
70. Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q. (2007). 172GT variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28:988-994. (Pubitemid 47072182)
71. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. (2000). XPD polymorphisms: Efects on DNA repair profciency. Carcinogenesis 21:551-555. (Pubitemid 30214005)
72. Mahaney BL, Meek K, Lees-Miller SP. (2009). Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417:639-650.
73. Maher VM, Ouellette LM, Curren RD, McCormick JJ. (1976). Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells. Nature 261:593-595.
74. Marin M. (2008). Folding at the rhythm of the rare codon beat. Biotechnol J 3:1047-1057.
75. Mateuca R, Aka PV, De Boeck M, Hauspie R, Kirsch-Volders M, Lison D. (2005). Infuence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol Lett 156:277-288. (Pubitemid 40292801)
76. Mateuca R, Lombaert N, Aka P V, Decordier I, Kirsch-Volders M. (2006). Chromosomal changes: Induction, detection methods and applicability in human biomonitoring. Biochimie 88:1515-1531. (Pubitemid 44762225)
77. Mateuca RA, Roelants M, Iarmarcovai G, Aka PV, Godderis L, Tremp A, Bonassi S, Fenech M, Bergé-Lefranc JL, Kirsch-Volders M. (2008). hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms infuence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23:35-41. (Pubitemid 351161350)
78. Navasumrit P, Arayasiri M, Hiang OM, Leechawengwongs M, Promvijit J, Choonvisase S, Chantchaemsai S, Nakngam N, Mahidol C, Ruchirawat M. (2008). Potential health effects of exposure to carcinogenic compounds in incense smoke in temple workers. Chem Biol Interact 173:19-31.
79. Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Bofetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ, Knudsen LE, Barale R, Fucic A. (2006). Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600:37-45.
80. Oberheitmann B, Frentzel-Beyme R, Hofmann W. (2001). An application of the challenge assay in boat builders exposed to low levels of styrene-a feasibility study of a possible biomarker for acquired susceptibility. Int J Hyg Environ Health 204:23-29. (Pubitemid 33031896)
81. Oesch F, Aulmann W, Platt KL, Doerjer G. (1987). Individual diferences in DNA repair capacities in man. Arch Toxicol Suppl 10:172-179. (Pubitemid 17012507)
82. Paterson MC, Smith PJ. (1979). Ataxia telangiectasia: An inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet 13:291-318.
83. Payne S. (2001). Smoke like a man, die like a man?: A review of the relationship between gender, sex and lung cancer. Soc Sci Med 53:1067-1080. (Pubitemid 32737547)
84. Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG, Scott D. (1999). Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 65:784-794. (Pubitemid 30468725)
85. Rondelli CM, El-Zein RA, Wicklife JK, Etzel CJ, Abdel-Rahman SZ. (2010). A comprehensive haplotype analysis of the XPC genomic sequence reveals a cluster of genetic variants associated with sensitivity to tobacco-smoke mutagens. Toxicol Sci 115:41-50.
86. Ronen A, Glickman BW. (2001). Human DNA repair genes. Environ Mol Mutagen 37:241-283. (Pubitemid 32411130)
87. Rothfuss A, Schütz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G. (2000). Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390-394. (Pubitemid 30070767)
88. Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. (1998). Radiation-induced micronucleus induction in lymphocytes identifes a high frequency of radiosensitive cases among breast cancer patients: A test for predisposition? Br J Cancer 77:614-620. (Pubitemid 28059469)
89. Setlow RB. (1985). Variation in DNA repair among people. In: Castellani E, ed. Epidemiology and quantitation of environmental risk in humans for radiation and other agents. New York: Plenum Press, pp. 205-212.
90. Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, Bosken CH, Amos CI, Wei Q. (2003). Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 107:84-88. (Pubitemid 37100089)
91. Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q. (2002). A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Int J Cancer 99:869-872. (Pubitemid 34575706)
92. Shen MR, Jones IM, Mohrenweiser H. (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604-608. (Pubitemid 28099464)
93. Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Tomas CB, Reding DJ, Hayes RB, Caporaso NE. (2011). Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis 32:69-73.
94. Siller E, DeZwaan DC, Anderson JF, Freeman BC, Barral JM. (2010). Slowing bacterial translation speed enhances eukaryotic protein folding efciency. J Mol Biol 396:1310-1318.
95. Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, Pokorna Z, Mareckova J, Hurychova D. (2001). Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ Health Perspect 109:41-45. (Pubitemid 32118024)
96. Spitz MR, Bondy ML. (1993). Genetic susceptibility to cancer. Cancer 72:991-995. (Pubitemid 23218015)
97. Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. (1995). Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4:99-103.
98. Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman SM, Khuri FR, Stefen-Batey L, Chamberlain RM, Schantz SP, Hong WK. (1997). Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 6:687-692. (Pubitemid 27427623)
99. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354-1357. (Pubitemid 34292555)
100. Stern MC, Umbach DM, Lunn RM, Taylor JA. (2002). DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939-943. (Pubitemid 35014902)
101. Takano K, Nakamura T, Sekiguchi M. (1991). Roles of two types of O6-methylguanine-DNA methyltransferases in DNA repair. Mutat Res 254:37-44.
102. Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. (2002). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: Role in mutagen sensitivity. Carcinogenesis 23:1003-1008. (Pubitemid 34752956)
103. Tuntawiroon J, Mahidol C, Navasumrit P, Autrup H, Ruchirawat M. (2007). Increased health risk in Bangkok children exposed to polycyclic aromatic hydrocarbons from trafc-related sources. Carcinogenesis 28:816-822. (Pubitemid 46523338)
104. Tutt A, Ashworth A. (2002). The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 8:571-576. (Pubitemid 35408215)
105. Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfeld PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. (2005a). In vitro sensitivity to ultraviolet B light and skin cancer risk: A case-control analysis. J Natl Cancer Inst 97:1822-1831. (Pubitemid 43033903)
106. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. (2005b). Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435CT afects mRNA stability. Pharmacogenet Genomics 15:693-704. (Pubitemid 41345321)
107. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. (2003a). From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2:901-908. (Pubitemid 37297454)
108. Wang Y, Liang D, Spitz MR, Zhang K, Dong Q, Amos CI, Wu X. (2003b). XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer 98:1701-1706. (Pubitemid 37238627)
109. Wei Q, Cheng L, Hong WK, Spitz MR. (1996a). Reduced DNA repair capacity in lung cancer patients. Cancer Res 56:4103-4107. (Pubitemid 26304997)
110. Wei Q, Gu J, Cheng L, Bondy ML, Jiang H, Hong WK, Spitz MR. (1996b). Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 56:3975-3979. (Pubitemid 26284747)
111. Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van Den Broecke R, Makar A, Marras E, Perletti G, Tierens H, Vral A. (2008). Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 47:137-148.
112. Willems P, De Ruyck K, Van Den Broecke R, Makar A, Perletti G, Tierens H, Vral A. (2009). A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. J Cancer Res Clin Oncol 135:1159-1168.
113. Wolfe KJ, Wicklife JK, Hill CE, Paolini M, Ammenheuser MM, Abdel-Rahman SZ. (2007). Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression. Pharmacogenet Genomics 17:897-905. (Pubitemid 350293790)
114. Wongvijitsuk S, Navasumrit P, Vattanasit U, Parnlob V, Ruchirawat M. (2011). Low level occupational exposure to styrene: Its effects on DNA damage and DNA repair. Int J Hyg Environ Health 214:127-137.
115. Wu X, Gu J, Spitz MR. (2007a). Mutagen sensitivity: A genetic predisposition factor for cancer. Cancer Res 67:3493-3495. (Pubitemid 46762125)
116. Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. (2007b). Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer 120:2687-2695. (Pubitemid 46651292)
117. Wu X, Spitz MR, Amos CI, Lin J, Shao L, Gu J, de Andrade M, Benowitz NL, Shields PG, Swan GE. (2006). Mutagen sensitivity has high heritability: Evidence from a twin study. Cancer Res 66:5993-5996.
118. Wu X, Yu H, Amos CI, Hong WK, Spitz MR. (2000). Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res 10 Suppl A:S26-S27. (Pubitemid 30641923)
119. Zhang J, Powell SN. (2005). The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 3:531-539. (Pubitemid 41567272)